Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism

FEMS Immunology and Medical Microbiology

Volumn 13, Issue 3, 1996, Pages 221-225

  Tarnvik A ^a   Ericsson, M ^a   Golovliov, I ^a,b   Sandstrom G ^a,b   Sjostedt A ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

Cell mediated immunity; Francisella tularensis; T cell; Tularemia

Indexed keywords

CYTOKINE; TULAREMIA VACCINE; VACCINE;

CELLULAR IMMUNITY; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TULAREMIA;

EID: 0342902628     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(95)00108-5     Document Type: Conference Paper

References (41)

1. Anthony, L.S.D. and Kongshavn, P.A.L. (1987) Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb. Pathogen. 2, 3-14.
2. Fortier, A.H., Slayter, M.V., Ziemba, R., Meltzer, M.S. and Nacy, C.A. (1991) Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59, 2922-2928.
3. Tärnvik, A. (1989) Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11, 440-451.
4. Forsman, M., Sandström, G. and Sjöstedt, A. (1994) Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phytogeny of the genus and for identification of strains by PCR. Int. J. Syst. Bacteriol. 44, 38-46.
5. Francis, E. and Evans, A.C. (1926) Agglutination, cross-agglutination, and agglutinin absorption in tularaemia. Public Health Rep. 41, 1273-1295.
6. Ohara, S., Sato, T. and Homma, M. (1974) Serologic studies on Francisella tularensis. Francisella novicida. Yersinia philomiragica, and Brucella abortus. Int. J. Syst. Bacteriol. 24, 191-196.
7. Koskela, P. and Herva, E. (1982) Immunity against Francisella tularensis in northern Finland. Scand. J. Infect. Dis. 14, 195-199.
8. Tärnvik, A., Eriksson, M., Sandström, G. and Sjöstedt, A. (1992) Francisella tularensis - a model for studies of the immune response to intracellular bacteria in man. Immunology 76, 349-354.
9. Allen, W.P. (1962) Immunity against tularemia: passive protection of mice by transfer of immune tissues. J. Exp. Med. 115, 411-420.
10. Thorpe, B.D. and Marcus, S. (1965) Phagocytosis and intracellular fate of Pasteurella tularensis. III. In vivo studies with passively transferred cells and sera. J. Immunol. 94, 578-585.
11. Eigelsbach, H.T., Hunter, D.H., Janssen W.A., Dangerfield, H.G. and Rabinowitz, S.G. (1975) Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection. Infect. Immun. 12, 999-1005.
12. Woodward, J.M., Stansberry, M.H., Presswood, W.G. and Fox, J.B. (1964) Cellular immunity of rats to tularemia. Can. J. Microbiol. 10, 573-577.
13. Kostiala, A.A.I., McGregor, D.D. and Logic, P.S. (1975) Tularemia in the rat. I. The cellular basis of host resistance to infection. Immunology 28, 855-869.
14. Burke, D.S. (1977) Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J. Infect. Dis. 135, 55-60.
15. Tigertt, W. D. (1962) Soviet viable Pasteurella tularensis vaccines: a review of selected articles. Bacteriological Rev. 26, 354-373.
16. Pollitzer, R. (1967) History and incidence of tularemia in Soviet Union - a review. Bronx. NY: The Institute of Contemporary Russian Studies, Fordham University.
17. Hornick, R.B. and Eigelsbach, H.T. (1966) Aerogenic immunization of man with live tularemia vaccine. Bacteriological Rev. 30,. 532-538.
18. Sjöstedt, A., Sandström, G. and Tärnvik, A. (1990) Several membrane polypeptides of the live vaccine strain Francisella tularenis LVS stimulate T cells from naturally infected individuals. J. Clin. Microbiol. 28, 43-48.
19. + T cells of primed humans. Immunology 76, 584-592.
20. + T cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect. Immun. 62, 5603-5607.
21. Elkins, K.L., Rhinehart-Jones, T., Nacy, C.A., Winegar, R.K. and Fortier, A.H. (1993) T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61, 823-829.
22. Fortier, A.M., Polsinelli, T., Green, S.J. and Nacy, C.A. (1992) Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60, 817-825.
23. Drabick, J.J., Narayanan, R.B., Williams, J.C., LeDuc, J.W. and Nacy, C.A. (1994) Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am. J. Med. Sci. 308, 83-87.
24. Sjöstedt, A., Conlan, J.W. and North, R.J. (1994) Neutrophils are critical for host defence against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62, 2779-2783.
25. Sumida, T., Maeda, T., Takahashi, H., Yoshida, S., Yonaha, F., Sakamoto, A., Tomioka, H., Koike, T. and Yoshida S. (1992) Predominant expansion of Vγ9/Vδ2 T cells in a tularemia patient. Infect. Immun. 60, 2554-2558.
26. Ericsson, M., Sandström, G., Sjöstedt, A. and Tärnvik, A. (1994) Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J. Infect. Dis. 70, 110-114.
27. Sandström, G., Tärnvik. A. and Wolf-Watz, H. (1987) Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J. Clin. Microbiol. 25, 641-644.
28. Surcel, H.-M. (1990) Diversity of Francisella tularensis antigens recognized by human lymphocytes. Infect. Immun. 58, 2664-2668.
29. Sjöstedt, A., Sandström, G., Tärnvik, A. and Jaurin, B. (1989) Molecular cloning and expression of a T-cell stimulating membrane protein from Francisella tularensis. Microb. Pathogen. 6, 403-414.
30. Sjöstedt, A., Sandström, G., Tärnvik, A. and Jaurin, B. (1990) Nucleotide sequence and T-cell epitopes of a membrane protein of Francisella tularensis. J. Immunol. 145, 311-317.
31. Sjöstedt, A., Tärnvik, A. and Sandström, G. (1991) The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein. Infect. Immun. 59, 3163-3168.
32. Lowrie, D.B., Tascon, R.E., Colston, M.J. and Silva, C.L. (1994) Towards a DNA vaccine against tuberculosis. Vaccine 12, 1537-1540.
33. Ericsson, M., Tärnvik, A., Kuoppa, K., Sandström, G. and Sjöstedt, A. (1993) Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect. Immun. 62, 178-183.
34. Sjöstedt, A., Sandström, G. and Tärnvik, A. (1992) Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect. Immun. 60, 2855-2862.
35. Golovliov, I., Ericsson, M., Åkerblom, L., Sandström, G., Tärnvik, A. and Sjöstedt, A. (1995) Adjuvanticity of ISCOMs incorporating a T-cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine 13, 261-267.
36. Lövgren, K., Käberg, H. and Morein, B. (1990) An experimental influenza subunit vaccine (ISCOM): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin. Exp. Immunol. 82, 435-439.
37. h1 cells. Immunol. Today, 14, 335-338.
38. Ferrick, D.A., Schrenzel, M.D., Mulvania, T., Hsieh, B., Ferlin, W.G. and Lepper, H. (1995) Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 373, 255-257.
39. Golovliov, I., Sandström, G., Ericsson, M., Sjöstedt A. and Tärnvik, A. (1995) Cytokine expression in the liver during the early phase of murine tularemia. Infect. Immun. 63, 534-538.
40. Tang, Y.-W. and Graham, B.S. (1994) Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94, 1953-1958.
41. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.